Gilead Sciences Inc (NASDAQ:GILD)

During the Trading Day
102.27 +1.48 / +1.47%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
101.79 -0.4783 / -0.47%
 
Volume: 121.6K
Bristol-Myers, Celgene Pair Up for Oncology Combo Treatments - Analyst Blog
6:04pm / Zacks.com
Roche's Avastin Approved by FDA for Advanced Cervical Cancer - Analyst Blog
Aug 18 / Zacks.com
Achillion Attains 52-Week High on ACH-3102 Patent Protection - Analyst Blog
5:47pm / Zacks.com
Gilead Scores Legal Victory Over Roche for Sovaldi, Shares Up - Analyst Blog
Aug 18 / Zacks.com
Amicus Therapeutics (FOLD) Soars on Fabry Drug Trial Results - Analyst Blog
5:30pm / Zacks.com
Playing the New Hepatitis C Drugs
Aug 18 / TheStreet.com
3 Stocks Boosting The Drugs Industry Higher
1:14pm / TheStreet.com
3 Big Stocks on Traders' Radars
Aug 18 / TheStreet.com
Jim Cramer's Stop Trading: Don't Worry About Gilead Sciences
11:14am / TheStreet.com
#PreMarket Primer: Monday, August 18: Jackson Hole Draws Market Attention
Aug 18 / Benzinga
Gilead (GILD) Hits 52-Week High Thanks to Sovaldi - Analyst Blog
10:39am / Zacks.com
Markets Close The Week On Negative Note As Ukraine Worries Mount
Aug 15 / Benzinga
Amicus Therapeutics (FOLD) Worth Watching: Stock Rises 20.4% - Tale of the Tape
10:21am / Zacks.com
A Double Dose of Good News for Gilead Sciences, Inc.
Aug 15 / MotleyFool.com
Discovery Laboratories (DSCO) Worth Watching: Stock Up 6.9% - Tale of the Tape
10:05am / Zacks.com
Notable 52-Week Highs and Lows of the Day 8/15: (ACHN) (GILD) (BITA) High; (BAA) (XIN...
Aug 15 / Investing Channel
Synthetic Biologics (SYN) Jumps: Stock Adds 16% in Session - Tale of the Tape
9:31am / Zacks.com
Why Achillion Pharmaceuticals, Inc. Stock Soared
Aug 15 / MotleyFool.com
Emergent BioSolutions, MorphoSys Tie Up on Cancer Candidate - Analyst Blog
Aug 20 / Zacks.com
3 Drugs Stocks Moving The Industry Upward
Aug 15 / TheStreet.com
Hospira Sues FDA on Generic Precedex Approval, Shares Down - Analyst Blog
Aug 20 / Zacks.com
Array BioPharma Falls Despite Narrower-than-Expected Q4 Loss - Analyst Blog
Aug 15 / Zacks.com
3 Reasons Gilead Science, Inc.bs Stock Could Rise
Aug 20 / MotleyFool.com
Gilead (GILD): Today's Pre-Market Leader Stock
Aug 15 / TheStreet.com
Healthcare Enjoys Growth Trends: 3 Medical Stocks to Buy - Analyst Blog
Aug 20 / Zacks.com
Analysts' Actions: Davita, Gilead, G&K Services, Omnivision, More
Aug 15 / TheStreet.com
Record Earnings & Stronger Growth in Q2 - Earnings Trends
Aug 20 / Zacks.com
UK watchdog backs B#400 a day hepatitis C drug
Aug 14 / FT.com
Record Earnings & Stronger Growth in Q2 - Earnings Outlook
Aug 20 / Zacks.com
Amgen's FOCUS Study on Multiple Myeloma Drug Kyprolis Fails - Analyst Blog
Aug 14 / Zacks.com
Oncothyreon (ONTY) Slumps, Tecemotide Fails Phase I/II Study - Analyst Blog
Aug 20 / Zacks.com
Strong Earnings Season Winding Down - Earnings Trends
Aug 14 / Zacks.com
Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains ...
Aug 20 / Zacks.com
Strong Earnings Season Winding Down - Earnings Outlook
Aug 14 / Zacks.com
Will Roche (RHHBY) Buy the Remaining Stake in Chugai? - Analyst Blog
Aug 19 / Zacks.com
Should Gilead Sciences (GILD) Be in Your Portfolio? - Stocks in the News
Aug 14 / Zacks.com
Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 - Analyst Blog
Aug 19 / Zacks.com
Stock Market News for August 14, 2014 - Market News
Aug 14 / Zacks.com
Pfizer Submits Palbociclib Marketing Application to the FDA - Analyst Blog
Aug 19 / Zacks.com
Dendreon Down on Default Risk, Reports Narrower Q2 Loss - Analyst Blog
Aug 13 / Zacks.com
Biogen Strengthens MS Portfolio with Plegridy FDA Approval - Analyst Blog
Aug 19 / Zacks.com
BioDelivery Sciences Q2 Loss Narrows, Up on Solid Revenues - Analyst Blog
Aug 13 / Zacks.com
PDL BioPharma Misses on Q2 Earnings due to Higher Expenses - Analyst Blog
Aug 19 / Zacks.com
Intercept Pharmaceuticals Posts Earnings, Pipeline in Focus - Analyst Blog
Aug 13 / Zacks.com
Celladon Corp. (CLDN) Jumps: Stock Adds 11.3% in Session - Tale of the Tape
Aug 19 / Zacks.com
Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
Aug 13 / Zacks.com
Achillion Pharmaceuticals Soars on Mid-Stage HCV Study Data - Analyst Blog
Aug 18 / Zacks.com
Celladon (CLDN) Falls: Stock Goes Down 6.2% - Tale of the Tape
Aug 13 / Zacks.com
Should Achillion Pharma (ACHN) Be In Your Portfolio Now? - Stocks in the News
Aug 18 / Zacks.com
Regeneron's Eye Drug Eylea Cleared in the EU for DME - Analyst Blog
Aug 12 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.